Share Prices & Company Research

Market News

18 Mar 2021 | 18:29

EMA reiterates AstraZeneca Covid-19 vaccine is 'safe and effective'

(Sharecast News) - Europe's drugs regulator reiterated that the Covid-19 vaccine developed by AstraZeneca and the University of Oxford is "safe and effective". Speaking on Thursday, the director of the European Medicines Agency, Emer Cooke, also said it was "clear" that the benefits from the vaccine, which protects people from the risk of death or hospitalisation, outweigh the risks.

Cooke's statements followed an inquiry by the watchdog into 30 reported cases of blood-clotting among 5.0m people who had received the vaccine.

"If it were me, I would be vaccinated tomorrow," she said.

Financial markets and governments around the world had been eagerly awaiting the conclusions of the watchdog's probe.

In particular, the EMA was concerned by the risk of blood clots developing in the heads of patients.

As a precaution, France, Germany and Italy had temporarily suspended inoculations with the shot.

Nevertheless, the agency announced that it would update its guidance for the vaccine so that patients and healthcare workers were aware of the potential risks.

A separate review by AstraZeneca of 17m individuals who had been vaccinated in the European Union and UK had found no evidence of a higher risk of blood clots among recipients of the vaccine.
Get in touch today
Join Redmayne Bentley
Talk to us now about opening a new account or transferring your account from another provider
0113 243 6941
Get in touch today
Contact your local office
Contact your local office to find out more
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
Continuing our Personal Service: View our Latest COVID-19 Update: 30th April 2021
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.